vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and ON24 INC. (ONTF). Click either name above to swap in a different company.
ON24 INC. is the larger business by last-quarter revenue ($34.6M vs $21.2M, roughly 1.6× Autolus Therapeutics plc). ON24 INC. runs the higher net margin — -18.8% vs -373.3%, a 354.5% gap on every dollar of revenue. ON24 INC. produced more free cash flow last quarter ($-2.2M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
ON24 Inc., a San Francisco-based company, is a cloud-based platform that develops and sells web-based webinar, virtual conferencing, content hub, and landing page applications as a service for marketing and sales teams in B2B organizations. In 2023 it expanded its offerings to include generative AI services.
AUTL vs ONTF — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $34.6M |
| Net Profit | $-79.1M | $-6.5M |
| Gross Margin | — | 74.9% |
| Operating Margin | -337.9% | -23.5% |
| Net Margin | -373.3% | -18.8% |
| Revenue YoY | — | -5.6% |
| Net Profit YoY | 3.6% | 26.8% |
| EPS (diluted) | $-0.30 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $34.6M | ||
| Q3 25 | $21.2M | $34.6M | ||
| Q2 25 | $20.9M | $35.3M | ||
| Q1 25 | $9.0M | $34.7M | ||
| Q4 24 | — | $36.7M | ||
| Q3 24 | $0 | $36.3M | ||
| Q2 24 | $0 | $37.3M | ||
| Q1 24 | $10.1M | $37.7M |
| Q4 25 | — | $-6.5M | ||
| Q3 25 | $-79.1M | $-6.4M | ||
| Q2 25 | $-47.9M | $-7.3M | ||
| Q1 25 | $-70.2M | $-8.7M | ||
| Q4 24 | — | $-8.9M | ||
| Q3 24 | $-82.1M | $-11.4M | ||
| Q2 24 | $-58.3M | $-11.2M | ||
| Q1 24 | $-52.7M | $-10.7M |
| Q4 25 | — | 74.9% | ||
| Q3 25 | — | 74.7% | ||
| Q2 25 | — | 75.1% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | 74.5% | ||
| Q3 24 | — | 74.3% | ||
| Q2 24 | — | 74.5% | ||
| Q1 24 | — | 74.1% |
| Q4 25 | — | -23.5% | ||
| Q3 25 | -337.9% | -23.1% | ||
| Q2 25 | -292.6% | -26.0% | ||
| Q1 25 | -726.3% | -30.1% | ||
| Q4 24 | — | -32.1% | ||
| Q3 24 | — | -36.7% | ||
| Q2 24 | — | -35.0% | ||
| Q1 24 | -384.1% | -33.1% |
| Q4 25 | — | -18.8% | ||
| Q3 25 | -373.3% | -18.4% | ||
| Q2 25 | -229.0% | -20.6% | ||
| Q1 25 | -781.1% | -25.1% | ||
| Q4 24 | — | -24.2% | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | — | -29.9% | ||
| Q1 24 | -522.1% | -28.4% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.30 | $-0.15 | ||
| Q2 25 | $-0.18 | $-0.17 | ||
| Q1 25 | $-0.26 | $-0.21 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | $-0.31 | $-0.27 | ||
| Q2 24 | $-0.22 | $-0.27 | ||
| Q1 24 | $-0.24 | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $37.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $139.4M |
| Total Assets | $661.9M | $228.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.0M | ||
| Q3 25 | $86.1M | $47.2M | ||
| Q2 25 | $123.8M | $37.7M | ||
| Q1 25 | $95.8M | $26.8M | ||
| Q4 24 | — | $14.9M | ||
| Q3 24 | $657.1M | $11.0M | ||
| Q2 24 | $705.9M | $15.5M | ||
| Q1 24 | $758.5M | $18.3M |
| Q4 25 | — | $139.4M | ||
| Q3 25 | $265.5M | $144.3M | ||
| Q2 25 | $346.5M | $150.0M | ||
| Q1 25 | $371.1M | $153.7M | ||
| Q4 24 | — | $159.4M | ||
| Q3 24 | $477.0M | $164.9M | ||
| Q2 24 | $527.8M | $170.8M | ||
| Q1 24 | $582.0M | $174.4M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | $661.9M | $224.8M | ||
| Q2 25 | $721.0M | $235.1M | ||
| Q1 25 | $746.3M | $245.8M | ||
| Q4 24 | — | $251.0M | ||
| Q3 24 | $827.5M | $250.9M | ||
| Q2 24 | $853.6M | $259.0M | ||
| Q1 24 | $901.4M | $269.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-1.1M |
| Free Cash FlowOCF − Capex | $-72.3M | $-2.2M |
| FCF MarginFCF / Revenue | -341.2% | -6.4% |
| Capex IntensityCapex / Revenue | 20.8% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $4.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-67.9M | $2.5M | ||
| Q2 25 | $-72.8M | $2.6M | ||
| Q1 25 | $-75.6M | $3.4M | ||
| Q4 24 | — | $985.0K | ||
| Q3 24 | $-76.7M | $295.0K | ||
| Q2 24 | $-51.1M | $1.4M | ||
| Q1 24 | $-40.5M | $2.1M |
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-72.3M | $2.2M | ||
| Q2 25 | $-80.1M | $2.1M | ||
| Q1 25 | $-83.8M | $1.9M | ||
| Q4 24 | — | $424.0K | ||
| Q3 24 | $-86.3M | $143.0K | ||
| Q2 24 | $-51.9M | $898.0K | ||
| Q1 24 | $-41.0M | $1.1M |
| Q4 25 | — | -6.4% | ||
| Q3 25 | -341.2% | 6.2% | ||
| Q2 25 | -382.6% | 5.9% | ||
| Q1 25 | -933.1% | 5.6% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | -406.8% | 2.9% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | 20.8% | 1.1% | ||
| Q2 25 | 34.8% | 1.4% | ||
| Q1 25 | 91.8% | 4.2% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 5.3% | 2.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
